Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Gayatri BioOrganics Ltd

GAYATRIBI
BSE
19.20
4.80%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Gayatri BioOrganics Ltd

GAYATRIBI
BSE
19.20
4.80%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
151Cr
Close
Close Price
19.20
Industry
Industry
Starch
PE
Price To Earnings
PS
Price To Sales
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM
10.26%
Peer Comparison
How does GAYATRIBI stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
GAYATRIBI
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
200000000000
Growth YoY
Revenue Growth YoY%
-100.0
Expenses
ExpensesCr
200000000000
Operating Profit
Operating ProfitCr
-100000000000
OPM
OPM%
-38.3
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-100000000000
Tax
TaxCr
000000000000
PAT
PATCr
-100000000000
Growth YoY
PAT Growth YoY%
-378.6-25.075.6-16.765.7-5.0-63.6-14.326.1-23.8-16.7-37.5
NPM
NPM%
-40.1
EPS
EPS
-0.10.00.00.00.00.00.00.00.00.00.00.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
257138801731550002000
Growth
Revenue Growth%
19.5-46.1-42.3117.6-10.3-100.0-100.0
Expenses
ExpensesCr
2411631291971591112101
Operating Profit
Operating ProfitCr
15-25-49-24-4-1-1-1-1-10-1
OPM
OPM%
6.0-18.0-61.8-13.8-2.3-46.1
Other Income
Other IncomeCr
11-1712285000000
Interest Expense
Interest ExpenseCr
91312050000000
Depreciation
DepreciationCr
225790000000
PBT
PBTCr
5-39-83-19-1684-1-1-1-1-1-1
Tax
TaxCr
100000000000
PAT
PATCr
4-39-83-19-1684-1-1-1-1-1-1
Growth
PAT Growth%
190.5-1,084.9-113.476.819.0644.7-100.60.3-103.732.6-6.7-18.4
NPM
NPM%
1.5-28.0-103.7-11.0-10.0-60.6
EPS
EPS
0.3-6.3-10.6-2.7-1.910.7-0.1-0.1-0.1-0.1-0.1-0.1

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
516279797979797979797979
Reserves
ReservesCr
-41-80-160-181-196-111-112-112-113-114-115-115
Current Liabilities
Current LiabilitiesCr
8212418424626034343434343434
Non Current Liabilities
Non Current LiabilitiesCr
19152222222344
Total Liabilities
Total LiabilitiesCr
1421421051451453322222
Current Assets
Current AssetsCr
88881051451453322222
Non Current Assets
Non Current AssetsCr
55540000000000
Total Assets
Total AssetsCr
1421421051451453322222

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1-26-14-3-185-10-1-1-1
Investing Cash Flow
Investing Cash FlowCr
-7-1-100000000
Financing Cash Flow
Financing Cash FlowCr
4281600000111
Net Cash Flow
Net Cash FlowCr
-201-3-185-10000
Free Cash Flow
Free Cash FlowCr
1-27-16-3-185-10-1-1-1
CFO To PAT
CFO To PAT%
27.368.416.613.73.8100.1104.081.555.8101.975.8
CFO To EBITDA
CFO To EBITDA%
7.0106.727.911.016.3-13,885.1104.281.673.4130.5122.4

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
445713052171051148563954
Price To Earnings
Price To Earnings
11.30.00.00.00.00.10.00.00.00.00.0
Price To Sales
Price To Sales
0.20.41.60.30.133.8
Price To Book
Price To Book
4.4-3.2-1.6-0.5-0.1-0.3-1.5-4.4-1.6-1.1-1.5
EV To EBITDA
EV To EBITDA
6.0-5.6-3.4-3.7-14.2-73.3-172.1-368.7-119.9-142.5-201.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.51.445.318.428.64.8
OPM
OPM%
6.0-18.0-61.8-13.8-2.3-46.1
NPM
NPM%
1.5-28.0-103.7-11.0-10.0-60.6
ROCE
ROCE%
23.7-38.5154.428.213.23,219.7-23.4-30.4-65.3-44.5-44.6
ROE
ROE%
39.1217.5101.918.713.3-260.11.51.52.91.92.0
ROA
ROA%
2.8-27.3-78.9-13.2-10.72,730.4-19.2-22.2-62.5-43.2-43.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Gayatri BioOrganics Limited is an Indian industrial manufacturer specializing in the production of **Starch**, its **derivatives**, and related **by-products**. The company focuses on the development of **customized applications** for value-added starch derivatives to serve diverse industrial requirements. Listed on the **BSE Limited (ISIN: INE052E01015)**, the company is currently navigating a strategic transition phase characterized by promoter consolidation and a restructuring of its manufacturing operations. --- ### **Core Operations and Industrial Infrastructure** The company maintains a manufacturing presence across two primary locations in Southern India, focusing on a **single reportable segment** of starch and related products. * **Manufacturing Footprint:** Production facilities are located in the states of **Telangana** and **Karnataka**. * **Corporate Hub:** The registered office is situated in **Hyderabad, Telangana**. * **Product Portfolio:** * **Maize Starch:** Primary industrial starch products. * **Starch Derivatives:** Modified starches for specialized industrial use. * **Value-Added Applications:** Customized starch solutions tailored to specific client requirements. * **By-products:** Related outputs from the starch manufacturing process. --- ### **Strategic Promoter Consolidation and Ownership Structure** As of **July 2024**, Gayatri BioOrganics is undergoing a significant consolidation of its leadership and ownership structure. This **inter-se transfer** of equity among the promoter group is designed to streamline shareholding under primary leadership, potentially simplifying future corporate actions and decision-making. The restructuring is conducted under **Regulation 29 (1) & (2)** and **Regulation 10** of the **SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011**. **Key Acquisition Details (July 2024):** The lead promoter, **T V Sandeep Kumar Reddy**, initiated the acquisition of **1,26,48,171** fully paid-up equity shares through off-market transactions (gifts and purchases). | Transferor / Donor Entity | Shares Transferred | % of Holding | | :--- | :--- | :--- | | **Tikkavarapu Sarita Reddy** | **48,80,279** | **6.19%** | | **TSR Holdings Private Limited** | **20,26,000** | **2.57%** | | **Subbarami Reddy Tikkavarapu** | **16,25,000** | **2.06%** | | **Gayatri Fin Holdings Private Limited** | **15,70,950** | **1.99%** | | **Indira Subbaramireddy Tikkavarapu** | **45,602** | **0.06%** | | **Total Acquisition Volume** | **1,26,48,171** | **-** | --- ### **Financial Profile and Capital Structure** The company’s financial position is defined by a transition following a **Business Transfer Agreement (BTA)** in **November 2016**, which involved the transfer of manufacturing units. While the company has seen a modest resumption of revenue, it continues to manage a significant debt burden and negative net worth. **Comparative Financial Performance:** | Metric | FY 2022-23 | FY 2021-22 | | :--- | :--- | :--- | | **Total Revenue** | **₹ 166.74 Lakhs** | **Nil** | | **Net Loss** | **₹ 1.01 Crore** | **₹ 49.61 Lakhs** | | **Reserves & Retained Earnings** | **₹ (11,327.36) Lakhs** | **-** | | **Dividend Recommended** | **Nil** | **Nil** | **Capital and Debt Composition:** * **Authorized Share Capital:** **₹ 90 Crore** (9,00,00,000 equity shares of **₹ 10** each). * **Paid-up Share Capital:** **₹ 78.79 Crore** (7,87,88,142 equity shares of **₹ 10** each). * **Unsecured Term Loans (Non-Current):** Totaling **₹ 295.73 Crore** (increased from **₹ 225.73 Crore**). * **Promoter Debt:** **₹ 182.79 Crore** provided by **Mr. T Sandeep Reddy**. Following the 2016 BTA, interest on this loan was waived (previously **15% p.a.**). It currently has **no fixed repayment term** and is repayable only upon achieving **adequate cash profits**. * **Inter-Corporate Deposits (ICD):** **₹ 112.94 Crore**, carrying an interest rate of **18% p.a.** (Standard inter-corporate loans are generally carried at **15% p.a.**). --- ### **Operational Stability and "Going Concern" Status** Despite a negative net worth of **₹ (113.27) Crore**, the company continues to operate on a **"going concern"** basis. This status is underpinned by: * **Promoter Support:** A **Comfort Letter** provided by the promoters ensures ongoing financial backing. * **Debt Management:** The company has **not** been declared a **Wilful Defaulter** by any bank or financial institution. * **Compliance:** There are no **unpaid or unclaimed dividends**, and no material changes have occurred in the **nature of business** or financial position since the last reporting date. --- ### **Enterprise Risk Management (ERM) Framework** The company employs a structured ERM framework overseen by a **Risk Management Committee**. Risks are prioritized based on **severity**, **likelihood**, and **detection effectiveness**, with **quarterly reviews** by senior management. #### **Financial & Liquidity Risks** * **Credit Risk:** Primarily concentrated in **Trade Receivables** and **Cash and Bank Balances**. The company monitors counterparty obligations closely to prevent financial loss. * **Liquidity Risk:** Managed by investing surplus funds in **marketable securities** and other financial instruments to support **short-term operational needs** and **long-term growth projects**. #### **Legal and Regulatory Exposures** * **Litigation:** The company is involved in ordinary-course legal proceedings and claims. * **Taxation:** Management is currently contesting specific **tax demands**. While the timing of cash outflows is subject to pending judgments, the company maintains that these will not have a **material adverse effect** on its financial position. #### **Strategic and Operational Oversight** The ERM framework actively monitors a broad spectrum of threats, including: * **Market and Strategic Risk** * **Security and IT Risk** * **Property and Reputational Risk** * **Regulatory and Compliance Risk** | Risk Category | Primary Focus Areas | Mitigation Strategy | | :--- | :--- | :--- | | **Credit** | Trade Receivables, Counterparty obligations | Monitoring concentration of credit and bank balances. | | **Liquidity** | Short-term operations, Long-term growth | Investment in **marketable securities**; maintaining surplus liquidity. | | **Legal** | Tax demands, Ordinary course litigation | Appellate process engagement; professional tax advisory. | | **Governance** | Enterprise-wide framework | **Quarterly reviews** by Senior Management and Board oversight. |